Login

Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Current assets
Deferred offering costs
Cash
Prepaid expenses
Income tax receivable
Total current assets
Non-current prepaid insurance
Marketable securities held in Trust Account
TOTAL ASSETS
Current liabilities
Accrued expenses
Accrued offering costs
Income tax payable
Total current liabilities
Warrant liabilities
Deferred tax liability
Excise tax payable
Deferred underwriting fee payable
TOTAL LIABILITIES
Class A common stock subject to possible redemption; 1,475,493 and 15,761,850 shares at redemption value at September 30, 2023 and December 31, 2022, respectively
STOCKHOLDERS’ DEFICIT
Common stock, value
Class A Common Stock
Class B Common Stock
Total common stock, value
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 4,312,500 shares issued and outstanding (1)
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,940,462 shares issued and outstanding at March 31, 2023 and December 31, 2022
Additional paid-in capital
Accumulated deficit
TOTAL STOCKHOLDERS’ DEFICIT
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support